Luckily for investors, the Australian share market is home to a good number of high quality blue chip shares to choose from.
Perhaps the hardest part is deciding which ones to buy over others. Two top blue chip shares that I think would be great options for a balanced portfolio are named below.
Here’s why I like them:
CSL Limited (ASX: CSL)
It is almost impossible to recommend blue chip shares and not choose CSL. I continue to believe the global biotherapeutics giant is one of the best companies on the share market and that it would make a fantastic core holding in most portfolios. CSL is made up of the CSL Behring and Seqirus businesses.
CSL Behring is the global leader in plasma therapies, whereas Seqirus is the second biggest in the influenza vaccines industry. I believe both are well-positioned for long term growth thanks to their leading therapies and vaccines, talented management teams, and their lucrative research and development pipelines.
REA Group Limited (ASX: REA)
I think REA Group is another blue chip share for investors to consider buying right now. I was very impressed with the property listings performance during the housing market downturn and the way it still achieved strong profit growth despite the tough trading conditions.
And while the housing market is now under pressure because of the pandemic (especially given the Melbourne lockdowns), I’m optimistic that it will recover swiftly once the crisis passes. This could mean a rebound in property listings from early in 2021. This, combined with price increases, new revenue streams, and its cost cutting, could see REA Group’s growth accelerate over the coming years. Overall, I think this makes REA Group a great blue chip to buy and hold for the long term.
These 3 stocks could be the next big movers in 2020
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
Find out the names of our 3 Post COVID Stocks – For FREE!
*Returns as of 6/8/2020
More reading
- Here are the highlights of this ASX reporting season
- ASX 200 Weekly Wrap: Blue chips, earnings drag ASX lower
- 2 of the best ETFs for investing in ASX shares
- Top brokers name 3 ASX shares to buy next week
- 2 ASX 50 shares to buy for your retirement portfolio
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Here’s why I would buy CSL and this ASX blue chip share appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/2Ywou9k
Leave a Reply